Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/GSK-Announces-Positive-Phase-IIa-Study-Results-For-New-First-In-Class-Candidate-Medicine-For-TB-Pati-42304230/?utm_source=whatsapp&utm_medium=social&utm_campaign=share